Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-anesthetic dose esketamine for postoperative analgesia in adult obstructive sleep apnea
ChiCTR2100042678Phase 4Recruiting
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in obstructive sleep apnea hypopnea syndrome (OSAHS) and postoperative pain (2 arms), sponsored by Dalian Municipal Central Hospital. Primary endpoints: Visual Analogue Scale pain score, Ramsay sedation score and 3 more. Started Mar 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)postoperative pain
Beyond the preview
Go deeper on ChiCTR2100042678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042678.